Scholar Rock Exec Says Its First Drug To Target Muscle Loss In Spinal Muscular Atrophy Has A Wholesale Acquisition Cost Of $11,659 For A Single Use Vial; Exec Says Co Expects The Annual Net Cost In The U.S. For A Typical Patient To Be ~$310,000

Loading news article.

Scholar Rock Exec Says Its First Drug To Target Muscle Loss In Spinal Muscular Atrophy Has A Wholesale Acquisition Cost Of $11,659 For A Single Use Vial; Exec Says Co Expects The Annual Net Cost In The U.S. For A Typical Patient To Be ~$310,000 | WAPE

Scholar Rock Exec Says Its First Drug To Target Muscle Loss In Spinal Muscular Atrophy Has A Wholesale Acquisition Cost Of $11,659 For A Single Use Vial; Exec Says Co Expects The Annual Net Cost In The U.S. For A Typical Patient To Be ~$310,000

Article summary

Related companies

Comments —